Arctic Therapeutics, founded with the mission to revolutionize drug development, leverages AI and bioinformatics to mitigate risks and reduce costs associated with traditional methods. The company focuses on creating effective treatments for diseases like Alzheimer's and dementia by harnessing over 20 years of international genomics research. Arctic Therapeutics collaborates with The Center for Applied Genomics at the Children’s Hospital of Philadelphia, aiming to repurpose existing drugs and expedite the development of new therapies.

Notable figures affiliated with Arctic Therapeutics include leading researchers from The Center for Applied Genomics. The company has achieved significant milestones in reducing the time and cost of drug development, making impactful strides in treating complex diseases. By integrating advanced AI and genomics, Arctic Therapeutics is poised to transform the pharmaceutical landscape, offering innovative solutions that address critical healthcare challenges.